McKesson (MCK) Competitors $711.32 -8.48 (-1.18%) Closing price 09/12/2025 03:59 PM EasternExtended Trading$714.50 +3.18 (+0.45%) As of 09/12/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MCK vs. HOLX, HQY, HSIC, MMSI, AMN, CRL, HUM, ITGR, WST, and CORShould you be buying McKesson stock or one of its competitors? The main competitors of McKesson include Hologic (HOLX), HealthEquity (HQY), Henry Schein (HSIC), Merit Medical Systems (MMSI), AMN Healthcare Services (AMN), Charles River Laboratories International (CRL), Humana (HUM), Integer (ITGR), West Pharmaceutical Services (WST), and Cencora (COR). These companies are all part of the "medical" sector. McKesson vs. Its Competitors Hologic HealthEquity Henry Schein Merit Medical Systems AMN Healthcare Services Charles River Laboratories International Humana Integer West Pharmaceutical Services Cencora McKesson (NYSE:MCK) and Hologic (NASDAQ:HOLX) are both large-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, media sentiment, profitability, valuation, dividends, analyst recommendations and risk. Which has more risk and volatility, MCK or HOLX? McKesson has a beta of 0.51, meaning that its share price is 49% less volatile than the S&P 500. Comparatively, Hologic has a beta of 0.57, meaning that its share price is 43% less volatile than the S&P 500. Do analysts rate MCK or HOLX? McKesson presently has a consensus target price of $725.10, suggesting a potential upside of 1.94%. Hologic has a consensus target price of $78.00, suggesting a potential upside of 21.02%. Given Hologic's higher possible upside, analysts plainly believe Hologic is more favorable than McKesson.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score McKesson 0 Sell rating(s) 3 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 2.85Hologic 0 Sell rating(s) 8 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.59 Is MCK or HOLX more profitable? Hologic has a net margin of 13.79% compared to McKesson's net margin of 0.84%. Hologic's return on equity of 19.69% beat McKesson's return on equity.Company Net Margins Return on Equity Return on Assets McKesson0.84% -196.66% 5.66% Hologic 13.79%19.69%10.82% Do insiders and institutionals have more ownership in MCK or HOLX? 85.1% of McKesson shares are owned by institutional investors. Comparatively, 94.7% of Hologic shares are owned by institutional investors. 0.1% of McKesson shares are owned by insiders. Comparatively, 1.9% of Hologic shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Does the media prefer MCK or HOLX? In the previous week, McKesson had 13 more articles in the media than Hologic. MarketBeat recorded 39 mentions for McKesson and 26 mentions for Hologic. McKesson's average media sentiment score of 1.44 beat Hologic's score of 1.33 indicating that McKesson is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment McKesson 32 Very Positive mention(s) 4 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hologic 19 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has better earnings & valuation, MCK or HOLX? McKesson has higher revenue and earnings than Hologic. Hologic is trading at a lower price-to-earnings ratio than McKesson, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMcKesson$377.60B0.23$3.30B$25.0828.36Hologic$4.03B3.56$789.50M$2.4126.74 SummaryMcKesson and Hologic tied by winning 8 of the 16 factors compared between the two stocks. Get McKesson News Delivered to You Automatically Sign up to receive the latest news and ratings for MCK and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MCK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MCK vs. The Competition Export to ExcelMetricMcKessonMED/DENTAL IndustryMedical SectorNYSE ExchangeMarket Cap$89.53B$16.33B$5.87B$21.68BDividend Yield0.46%1.53%5.68%3.48%P/E Ratio28.3617.2774.5229.69Price / Sales0.232.32537.1770.24Price / Cash18.5213.5337.5625.00Price / Book-52.613.3512.164.58Net Income$3.30B$472.94M$3.28B$1.00B7 Day Performance3.54%-2.06%0.87%0.65%1 Month Performance7.32%-5.24%4.96%3.07%1 Year Performance37.11%4.02%60.74%14.34% McKesson Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MCKMcKesson4.5503 of 5 stars$711.32-1.2%$725.10+1.9%+39.2%$89.53B$377.60B28.3645,000News CoveragePositive NewsHOLXHologic4.9297 of 5 stars$66.54-0.3%$78.00+17.2%-19.9%$14.80B$4.03B27.617,063News CoveragePositive NewsHQYHealthEquity4.4423 of 5 stars$93.06+1.7%$119.77+28.7%+20.8%$8.02B$1.20B56.403,120Positive NewsHSICHenry Schein3.7403 of 5 stars$67.74-2.4%$76.67+13.2%+1.2%$8.21B$12.67B21.8525,000Positive NewsMMSIMerit Medical Systems4.816 of 5 stars$92.33-0.7%$107.00+15.9%-10.9%$5.47B$1.36B46.877,400Positive NewsAMNAMN Healthcare Services4.645 of 5 stars$20.97+0.6%$28.25+34.7%-58.3%$803.61M$2.98B-2.702,968News CoverageAnalyst ForecastShort Interest ↓Analyst RevisionCRLCharles River Laboratories International4.6181 of 5 stars$161.97-1.2%$175.69+8.5%-21.1%$7.97B$4.05B-121.7820,100Positive NewsAnalyst UpgradeHUMHumana4.4223 of 5 stars$310.39+0.8%$289.24-6.8%-14.8%$37.33B$117.76B23.8265,680Positive NewsITGRInteger3.8596 of 5 stars$106.01-0.9%$140.25+32.3%-19.6%$3.71B$1.72B46.7011,000WSTWest Pharmaceutical Services4.9764 of 5 stars$253.30+1.0%$320.71+26.6%-14.8%$18.21B$2.89B37.9210,600News CoveragePositive NewsCORCencora4.8019 of 5 stars$297.64+1.8%$311.25+4.6%+27.4%$57.71B$638.56M30.6246,000Positive News Related Companies and Tools Related Companies HOLX Competitors HQY Competitors HSIC Competitors MMSI Competitors AMN Competitors CRL Competitors HUM Competitors ITGR Competitors WST Competitors COR Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:MCK) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding McKesson Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share McKesson With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MCK Stock Alerts